JFG
PACB icon

Jefferies Financial Group’s Pacific Biosciences PACB Stock Holding History

Jefferies Financial Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$34.3K – 1682
2024
Q2 		$34.3K Hold
25,000
– – ﹤0.01% 1332
2024
Q1 		$93.8K Buy
+25,000
New +$146K ﹤0.01% 1447
2023
Q2 		– Sell
-39,200
Closed -$454K – 1921
2023
Q1 		$454K Buy
+39,200
New +$390K ﹤0.01% 1121

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jefferies Financial Group's PACB Position: Q2 2024 in Review

Jefferies Financial Group sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 1,011 shares — an estimated $2.04K sold.

Jefferies Financial Group first reported a position in PACB in Q1 2023 and held it in 2 quarters. The position peaked at $116K in Q1 2023. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Jefferies Financial Group reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 1,011 Pacific Biosciences shares in Q2 2024, an estimated $2.04K.
  • Jefferies Financial Group first reported a position in Pacific Biosciences in Q1 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Pacific Biosciences position peaked at $116K in Q1 2023.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.